Browse drugs

… of thyroid hormone receptors (TRα and TRβ). Treatment included propranolol, amitriptyline, loperamide and vitamin D supplementation, resul…

… age groups, countries of origin and socioeconomic backgrounds. SARS-CoV-2 infection during pregnancy was not associated with significant …

…). There was also no statistically significant effect of MMN or MQ-LNS compared with IFA on total weight gain in pregnancy, the rate o…

…th higher asthma prevalence when compared to non-users (C; e.g. combined pill, OR 1.09 (95% CI 1.06–1.12)), but use of the combined pill use …

…ereby 118 (80.8%) had GOLD 1/2 COPD and 28 patients (19.2%) had GOLD 3/4 COPD. 21 patients received an alternate respiratory diagnos…

…GA reduced the compressibility of DPPC by 54.12% (P=0.0354) and Alveofact by 37.71% (P=0.0116) in the first 5 cycles. EV raised the minim…

…03) 90 (81.5–97.5) 0.209 85 (65–111) 77 (65–119) 0.80 Post ICS (Flixotide 200 mcg twice daily) Post ICS Relvar (92 or 184 mcg daily) ACQ-…

…e pMDIs. The most common class of inhaler device collected were SABA (1,127), ICS/LABA (474), and ICS/LABA/LAMA inhalers (445). The …

… ongoing real-world observational study, previously showed that elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) improves clinical outcomes a…

…ith CF has allowed the clinical team to measure the response to Elexacaftor/Tezacaftor/Ivacaftor (ETI) therapy using pre and post LCI in a …

…er of respiratory medications; a higher proportion received any ICS (89% vs 74%), ICS+LABA (47% vs 14%), and SABA (99.5% vs 91.4%).…

…scular events. Biomarkers are needed to identify those at risk. Cystatin-C (Cys-C) is a cysteine protease inhibitor that predicts future c…